ATLAS fair value
ATLAS has no fair value for this stock today.
Kopran share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - General · National Stock Exchange of India · India
Prices as of Oct 27, 2026 · INR
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Kopran a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹225.82 and ₹271.81; in 9 out of 10, between ₹191.60 and ₹320.36. Estimated annual volatility is 55%.
ATLAS does not publish a fair value for KOPRAN.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks KOPRAN.NSE has traded between ₹107.00 and ₹295.83. Today it is 15.7% below that high and 133% above its low.
On the business: net margin is 3.6%; it trades at 53.8 times earnings.
Its beta is 0.89: it moves roughly in line with the market.
Kopran Ltd. is a pharmaceutical company engaged in the manufacturing and marketing of a wide range of healthcare products. The company's core operations revolve around producing pharmaceuticals, including formulations and active pharmaceutical ingredients (APIs).
Want to see everything about Kopran?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Kopran Ltd. is a pharmaceutical company engaged in the manufacturing and marketing of a wide range of healthcare products. The company's core operations revolve around producing pharmaceuticals, including formulations and active pharmaceutical ingredients (APIs).
48%: close to a coin flip. In half of the simulated outcomes, KOPRAN.NSE ends the month between ₹225.82 and ₹271.81.
Kopran's market capitalization is ₹13.4B. Its price-to-earnings (P/E) ratio is 53.8: you pay ₹53.8 for each ₹1.00 of yearly earnings.
Yes. KOPRAN.NSE's current dividend yield is 4.30% at today's price (₹249.30).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy